In a groundbreaking study published in Circulation: Cardiovascular Imaging, researchers have found that women, despite having less artery-clogging plaque than men, are not shielded from cardiovascular events. The study, which analyzed data from over 4,200 adults, reveals that women are at a higher risk of heart attacks and chest pain even with lower plaque levels, particularly after menopause.
The research, conducted by experts at Harvard Medical School and Massachusetts General Hospital, highlights a critical oversight in cardiovascular health assessments. Although women typically exhibit a lower prevalence of artery plaque, they are just as likely as men to suffer from serious heart conditions. This study underscores the need for gender-specific approaches in diagnosing and treating heart disease.
Key Findings and Implications
The study’s findings are based on health data from more than 4,200 adults, with over half being women. Participants, all of whom had stable chest pain and no prior history of coronary artery disease, were followed for about two years. They underwent diagnostic evaluations using coronary computed tomography angiography, a sophisticated imaging technique.
- 55% of women had plaque in their coronary arteries compared to 75% of men.
- Women had a median plaque volume of 78 mm3, while men had 156 mm3.
- Despite less plaque, 2.3% of women and 3.4% of men experienced heart attacks or were hospitalized for chest pain.
- Women’s risk increased at a 20% plaque burden, whereas men’s risk rose at 28%.
Dr. Borek Foldyna, the study’s senior author, emphasized the disproportionate risk that women face due to their smaller coronary arteries. “Moderate increases in plaque burden appear to have disproportionate risk in women, suggesting that standard definitions of high risk may underestimate risk in women,” he stated.
Expert Opinions and Broader Context
Stacey E. Rosen, M.D., a prominent figure in women’s health, highlighted the importance of recognizing the biological differences in how cardiovascular diseases manifest in men and women. “There is an overdue recognition of fundamental, biological differences in the way health conditions manifest in women vs. men,” she noted. Rosen’s insights reflect a growing awareness in the medical community about the need for gender-specific research and treatment strategies.
According to the American Heart Association’s 2026 Heart Disease and Stroke Statistics, cardiovascular disease remains the leading cause of death globally. In the U.S. alone, it accounted for 47.3% of deaths among women, totaling 433,254 fatalities.
Study Design and Historical Parallels
The study draws from the PROMISE trial, which involved adults with stable chest pain treated at 193 clinical sites across the U.S. and Canada. This trial is part of a broader effort to understand heart disease dynamics across different demographics. The lead author, Dr. Jan Brendel, emphasized the importance of such large-scale studies in uncovering nuanced insights about heart health.
Historically, heart disease research has predominantly focused on men, often overlooking the unique risk factors and symptoms that women face. This study represents a pivotal shift towards more inclusive research that can inform better healthcare practices for women.
Looking Ahead: Implications for Healthcare
The findings of this study have significant implications for how heart disease is diagnosed and treated in women. As the medical community continues to grapple with these revelations, there is a pressing need to revise current clinical guidelines to better address the distinct cardiovascular risks women face.
Future research should aim to further explore the underlying mechanisms that contribute to these gender differences in heart disease. By doing so, healthcare providers can develop more effective, personalized treatment plans that cater to the specific needs of women.
As awareness grows, it is crucial for both the public and healthcare professionals to advocate for more research and resources dedicated to understanding and combating heart disease in women. This study serves as a clarion call for change, urging a reevaluation of how we perceive and address cardiovascular health across genders.
